The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world outcomes following adverse events and dose reduction of first-line ibrutinib in Medicare beneficiaries with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).
 
Mazyar Shadman
Employment - Bristol-Myers Squibb (I)
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Bristol-Myers Squibb/Celgene; Fate therapeutics; Genentech; Genmab; Kite, a Gilead company; Lilly; Merck; MorphoSys; Nurix; Pharmacyclics; Regeneron
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); BeiGene (Inst); Bristol-Myers Squibb/Celgene; Celgene (Inst); Genentech (Inst); Genmab (Inst); Merck (Inst); MustangBio (Inst); Pharmacyclics (Inst); Sunesis Pharmaceuticals (Inst); TG Therapeutics (Inst); Vincerx Pharma (Inst)
 
Bhavini P. Srivastava
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie; Jazz Pharmaceuticals
 
Monika Salkar
Employment - AbbVie
Stock and Other Ownership Interests - AbbVie
 
Chadi Saifan
Employment - Abbvie
Stock and Other Ownership Interests - AbbVie
 
Barnabie C. Agatep
Employment - Inovalon
Consulting or Advisory Role - AbbVie
 
Barton Jones
Employment - Inovalon
Research Funding - Abbvie
 
Olga Ryan
Employment - Abbvie; AstraZeneca
Stock and Other Ownership Interests - Abbvie; AstraZeneca; Moderna Therapeutics
 
Shaffee Bacchus
Employment - AbbVie
Stock and Other Ownership Interests - Abbvie
 
Deborah M. Stephens
Consulting or Advisory Role - AbbVie; AstraZeneca; BeiGene; Bristol Myers Squibb Foundation; Celgene; CSL Behring; Epizyme; Genentech; Innate Pharma; Lilly; TG Therapeutics
Research Funding - Arqule; AstraZeneca; Iovance Biotherapeutics; Merck; Mingsight; Novartis